PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-05-04 (39)

Date Title Company
04-May-2021 Newron announces Paragraph IV ANDA filing for Xadago® (safinamide) in the USA Newron Pharmaceuticals S.p.A.